Stock Scorecard
Stock Summary for HUTCHMED (China) Ltd (HCM) - $16.75 as of 11/20/2024 4:09:29 PM EST
Total Score
12 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HCM
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HCM
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HCM
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HCM
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for HCM (28 out of 90)
Stock Price Rating (Max of 10) | 6 |
Historical Stock Price Rating (Max of 10) | 8 |
Stock Price Trend (Max of 10) | 2 |
Book Value (Max of 10) | 1 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 3 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 3 |
Price to Earnings (Max of 10) | 0 |
Latest News for for HCM
Financial Details for HCM
Company Overview |
|
---|---|
Ticker | HCM |
Company Name | HUTCHMED (China) Ltd |
Country | USA |
Description | HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. The company is headquartered in Central, Hong Kong. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 6/30/2024 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 16.75 |
Price 4 Years Ago | 32.02 |
Last Day Price Updated | 11/20/2024 4:09:29 PM EST |
Last Day Volume | 94,522 |
Average Daily Volume | 94,055 |
52-Week High | 21.92 |
52-Week Low | 11.93 |
Last Price to 52 Week Low | 40.40% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 22.60 |
Sector PE | 40.32 |
5-Year Average PE | -18.61 |
Free Cash Flow Ratio | 14.08 |
Industry Free Cash Flow Ratio | 12.03 |
Sector Free Cash Flow Ratio | 27.97 |
Current Ratio Most Recent Quarter | 2.81 |
Total Cash Per Share | 1.19 |
Book Value Per Share Most Recent Quarter | 0.87 |
Price to Book Ratio | 3.87 |
Industry Price to Book Ratio | 5.31 |
Sector Price to Book Ratio | 20.88 |
Price to Sales Ratio Twelve Trailing Months | 4.69 |
Industry Price to Sales Ratio Twelve Trailing Months | 11.82 |
Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
Analyst Buy Ratings | 8 |
Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
Total Shares Outstanding | 170,928,000 |
Market Capitalization | 2,863,044,000 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -84.20% |
Annual Earnings Growth | 124.57% |
Reported EPS 12 Trailing Months | -0.25 |
Reported EPS Past Year | 0.97 |
Reported EPS Prior Year | -2.68 |
Net Income Twelve Trailing Months | 160,466,500 |
Net Income Past Year | 100,780,000 |
Net Income Prior Year | -410,139,000 |
Quarterly Revenue Growth YOY | -42.60% |
5-Year Revenue Growth | 31.38% |
Operating Margin Twelve Trailing Months | -0.09 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 203,953,000 |
Total Cash Past Year | 283,589,000 |
Total Cash Prior Year | 313,278,000 |
Net Cash Position Most Recent Quarter | 155,764,000 |
Net Cash Position Past Year | 235,400,000 |
Long Term Debt Past Year | 48,189,000 |
Long Term Debt Prior Year | 18,104,000 |
Total Debt Most Recent Quarter | 48,189,000 |
Equity to Debt Ratio Past Year | 0.94 |
Equity to Debt Ratio Most Recent Quarter | 0.94 |
Total Stockholder Equity Past Year | 730,541,000 |
Total Stockholder Equity Prior Year | 610,367,000 |
Total Stockholder Equity Most Recent Quarter | 740,084,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 43,383,000 |
Free Cash Flow Per Share Twelve Trailing Months | 0.25 |
Free Cash Flow Past Year | 186,646,000 |
Free Cash Flow Prior Year | -305,263,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.68 |
MACD Signal | -0.40 |
20-Day Bollinger Lower Band | 15.95 |
20-Day Bollinger Middle Band | 18.58 |
20-Day Bollinger Upper Band | 21.21 |
Beta | 0.75 |
RSI | 28.68 |
50-Day SMA | 17.62 |
150-Day SMA | 16.08 |
200-Day SMA | 20.35 |
System |
|
Modified | 11/21/2024 2:38:32 AM EST |